FOXP3 and neoplasm: revealed that TGF‐β converts IFN‐γ‐producing Tbet+Th1 CD4+ T cells into immunosuppressive Tbet and Foxp3‐PD‐1 co‐expressing regulatory cells, thereby blocking anti‐tumor immune functions in both mice and humans.